UBS OCONNOR LLC - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$4,910,000,000
+287.2%
65,479
+159.0%
0.10%
+270.4%
Q1 2015$1,268,000,00025,2780.03%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 900,559$33,636,0003.14%
Redmile Group, LLC 557,761$20,777,0002.56%
SENZAR ASSET MANAGEMENT, LLC 79,000$2,951,0002.41%
Aureus Asset Management, LLC 134,465$5,022,0001.36%
REGENTATLANTIC CAPITAL LLC 193,454$7,226,0000.70%
PFM Health Sciences, LP 831,840$31,069,0000.62%
EAM Investors, LLC 55,201$2,056,0000.37%
Dynamic Technology Lab Private Ltd 5,560$207,0000.34%
Polar Capital LLP 350,000$13,038,0000.31%
Old West Investment Management, LLC 10,773$402,0000.24%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders